Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing...
Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
About this item
Full title
Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Clinical therapeutics, 2022-06, Vol.44 (6), p.901-912
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Highlights•Evolocumab showed better efficacy in patients with acute coronary syndrome •Evolocumab resulted in substantial reduction in LDL cholesterol levels •The benefits of evolocumab were consistent across the major subgroups
Alternative Titles
Full title
Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2666547565
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2666547565
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2022.04.010
